What is the dose and duration of sumatriptan (Imitrex) for a patient with migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sumatriptan Dosing for Acute Migraine

For oral sumatriptan, start with 50-100 mg at the onset of migraine symptoms (when pain is still mild), which can be repeated once after 2 hours if needed, with a maximum of 200 mg per 24 hours. 1, 2

Initial Dose Selection

  • The oral 50 mg dose offers the optimal balance of efficacy and tolerability for most patients, though the 100 mg dose provides greater efficacy and is well-tolerated by many 1, 2
  • The 25 mg dose is less effective and should be reserved for patients with hepatic impairment (maximum 50 mg single dose in this population) 2
  • Take the medication early when headache pain is still mild—this is crucial for maximum effectiveness, as waiting until pain becomes moderate or severe significantly reduces treatment success 3
  • Do not take sumatriptan during the aura phase, as there is no evidence of benefit when taken before headache onset 3

Alternative Routes for Faster Relief

If oral administration is inadequate or faster relief is needed:

  • Subcutaneous 6 mg provides the fastest relief (within 15 minutes) and highest efficacy (70-82% response rate), can be repeated once after 1 hour, maximum 12 mg per 24 hours 1, 4
  • Intranasal 5-20 mg can be repeated after 2 hours, maximum 40 mg per 24 hours 1, 4

Repeat Dosing for Headache Recurrence

  • Approximately 40% of patients experience headache recurrence within 8-12 hours after initial response, which can be effectively treated with a second dose 1, 3
  • For oral sumatriptan, wait at least 2 hours between doses 2
  • For subcutaneous sumatriptan, wait at least 1 hour between doses 1

Duration of Trial Period

  • Patients must try sumatriptan for 2-3 separate migraine episodes before determining if it is effective 3, 4
  • If inadequate response after proper dose optimization across multiple attacks, switch to a different triptan (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, or zolmitriptan), as different triptans work for different patients 1, 4

Combination Therapy for Insufficient Relief

  • If 100 mg sumatriptan provides insufficient relief, add an NSAID (naproxen, ibuprofen, or diclofenac) or acetaminophen rather than increasing triptan frequency 1, 3
  • Combination therapy of triptan plus NSAID is more effective than increasing triptan dose or frequency 1

Medication Overuse Warning

  • Limit use to no more than 4 headaches per 30-day period to avoid medication overuse headache 3, 2
  • The safety of treating more than 4 headaches in a 30-day period has not been established 2

Critical Contraindications

Absolute contraindications include:

  • Coronary artery disease, previous myocardial infarction, or Prinzmetal angina 1, 3
  • Hemiplegic or basilar migraine 1, 3
  • Uncontrolled hypertension 1
  • Within 24 hours of ergotamine derivatives or another triptan 1, 3
  • Current MAOI use or within 2 weeks of discontinuation 3
  • Pregnancy and severe hepatic impairment 3

Common Adverse Effects

  • Mild to moderate adverse events occur in 3-5% of patients, including chest pressure/heaviness, warmth sensation, nausea, vomiting, vertigo, and malaise 3, 4
  • Subcutaneous administration causes injection site reactions in approximately 30% of patients 4

References

Guideline

Sumatriptan Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Oral Sumatriptan Dosing for Acute Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Sumatriptan Administration and Efficacy for Migraine Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.